The University of Ottawa Heart Institute is Canada's largest cardiovascular health centre. It is located in Ottawa, Ontario, Canada.

During the past decade, University of Ottawa Heart Institute conducted 152 clinical trials. In the 10-year time frame, 152 clinical trials started and 38 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 22 clinical trials were completed. i.e. 38.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Ottawa Heart Institute" #1 sponsor was "Ottawa Heart Institute Research Corporation" with 135 trials, followed by "Abbott Medical Devices" with 9 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Population Health Research Institute" with 5 trials sponsored. Other sponsors include 109 different institutions and companies that sponsored additional 83 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Ottawa Heart Institute" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 39 trials as a collaborator, "Medtronic" with 13 trials as a collaborator, "Ottawa Heart Institute Research Corporation" with 12 trials as a collaborator, "Heart and Stroke Foundation of Ontario" with 10 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator. Other collaborators include 190 different institutions and companies that were collaborators in the rest 133 trials.

According to Clinical.Site data, the most researched conditions in "University of Ottawa Heart Institute" are "Coronary Artery Disease" (37 trials), "Atrial Fibrillation" (30 trials), "Heart Failure" (28 trials), "Cardiovascular Diseases" (13 trials) and "Acute Coronary Syndrome" (12 trials). Many other conditions were trialed in "University of Ottawa Heart Institute" in a lesser frequency.

Most popular intervention types in "University of Ottawa Heart Institute" are "Drug" (92 trials), "Device" (52 trials), "Procedure" (42 trials), "Other" (35 trials) and "Behavioral" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Clopidogrel" (6 trials), "Catheter ablation" (5 trials), "Ticagrelor" (4 trials) and "Aspirin" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Ottawa Heart Institute" are 267 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 89 active trials in "University of Ottawa Heart Institute". 5 are not yet recruiting, 51 are recruiting, 31 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 134 completed trials in University of Ottawa Heart Institute, 3 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in University of Ottawa Heart Institute, 6 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 40 trials, and there were also 112 trials that are defined as “Not Applicable".

University of Ottawa Heart Institute has several departments that took part in Clinical trials: "Division of Cardiac Surgery, University of Ottawa Heart Institute" - 3 trials, "Specialistic Cardiology&Hypertension Out-patient Clin,Kielce" - 3 trials, "University of Ottawa Heart Insitute - Prevention and Wellness Centre" - 2 trials